Anna Shurshalina

Interim Director of Pharmacovigilance and Risk Management Department

Egg Harbor Township, NJ

Work:
Employment History of Anna Shurshalina

Luitpold Pharmaceuticals

Interim Director of Pharmacovigilance and Risk Management Department


Bayer

Medical Director, Global Safety Lead, Oncology. Benefit Risk Management, Pharmacovigilance


Research Center of Obstetrics, Gynecology and Perinatology. Russian Academy of M

Physician, Clinical Associate Professor. ObGyn.


Teva Pharmaceuticals

Associate Director, Safety Physician, Global Patient Safety and Pharmacovigilance


American Medical Center. Moscow, Russia

Physician. Department of Surgery.


Genesis Biotechnology Group

Medical Affairs Specialist


AbbVie

Senior Medical Director, Oncology. Pharmacovigilance and Patient Safety


Luitpold Pharmaceuticals

Associate Medical Director

Schools:
Schools Attended by Anna Shurshalina

Russian Academy of Medical Science. Research Center of Obstetrics, Gynecology and Perinatology.


Kaplan University


Saint Joseph's University

Related:
Others that have worked at the same companies

Information Technology Specialist at genesisbiotechgroup.com


Oncology Field Specialist at luitpold.com

Regulatory Affairs Executive Director at luitpold.com

Microbiology Supervisor at luitpold.com

MSL Director of Women's Healthcare at bayer.com

Key Account Manager at bayer.com

Accounts Payable at bayer.com